Amino AsylumRetatrutide
Amino Asylum's Retatrutide evidence is sparse and mixed: one test showed strong purity but a -37% fill miss, while the follow-up passed identity, purity, and quantity at +9%. No batch identifiers mean priors carry much of the score.
The investigation traces Amino Asylum traffic into a Soma Chems successor route through redirects, reused address records, and GymNTonic labeling. It also maps Delaware no-record searches, affiliate-code promotion, FDA-raid reporting, and clone-risk channels.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Amino Asylum rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 19 Feb 2025 | Pass | w60rghl Tested | lab name | View COA | |||
| 14 Feb 2025 | Fail | ljv7n0u Tested | lab name | View COA | |||
About Amino Asylum test results from Finnrick
Amino Asylum is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 8 peptides and 15 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Amino Asylum peptides in this dataset are Tirzepatide (2 tests) and Retatrutide (2 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 15 recent tests.